In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions

Publication date: April 2021Source: Acta Pharmaceutica Sinica B, Volume 11, Issue 4Author(s): Ana L. Martínez-López, Carlos J. González-Navarro, Paula Aranaz, José L. Vizmanos, Juan M. Irache
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research